SCHEDULE: Grantham, Mayo, Van Otterloo & Co. Boosts Ameresco Stake
Beneficial Ownership Disclosure
Grantham, Mayo, Van Otterloo & Co. LLC has reported a beneficial ownership of 9.23% in Ameresco Inc. common stock.
Summary
- Grantham, Mayo, Van Otterloo & Co. LLC (GMO) has filed an Amendment No. 3 to Schedule 13G, disclosing its beneficial ownership in Ameresco Inc.
- GMO beneficially owns 3,203,393 shares of Ameresco Inc. common stock.
- This ownership represents 9.23% of the class of securities.
- GMO holds sole voting power and sole dispositive power over all 3,203,393 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Ameresco Inc.
Sentiment
Score: 7
Explanation: The disclosure of a significant beneficial ownership by a reputable institutional investor like Grantham, Mayo, Van Otterloo & Co. LLC is generally viewed as a positive signal of confidence in the issuer, Ameresco Inc.
Positives
- A significant institutional investor, Grantham, Mayo, Van Otterloo & Co. LLC, holds a substantial 9.23% stake in Ameresco Inc., indicating confidence in the company.
- The investment is stated to be in the ordinary course of business, suggesting a long-term investment strategy rather than an activist position.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the significant institutional ownership as a positive indicator of the company's value and future prospects, potentially increasing investor confidence.
- The stability of a large institutional holder can reduce volatility and provide a foundation for the stock price.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires the filing of this statement. |
| 11/05/2025 | Date of signature by Grantham, Mayo, Van Otterloo & Co. LLC's Chief Compliance Officer. |
Recommendation
holdThe filing indicates a significant institutional stake by Grantham, Mayo, Van Otterloo & Co. LLC, which is a positive signal of investor confidence. However, a Schedule 13G filing primarily discloses ownership and does not provide comprehensive financial or operational details to warrant a 'buy' or 'sell' recommendation. It suggests a 'hold' position, acknowledging the institutional backing while awaiting further fundamental information.
Keywords
Ameresco Inc, Grantham Mayo Van Otterloo & Co LLC, GMO, Common Stock, Beneficial Ownership, Institutional Investment, Schedule 13G, AMRC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.